RT Journal Article
SR Electronic
T1 Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.21.20196121
DO 10.1101/2020.09.21.20196121
A1 Im, Cindy
A1 Li, Nan
A1 Moon, Wonjong
A1 Liu, Qi
A1 Morton, Lindsay M.
A1 Leisenring, Wendy M.
A1 Howell, Rebecca M.
A1 Chow, Eric J.
A1 Sklar, Charles A.
A1 Wilson, Carmen L.
A1 Wang, Zhaoming
A1 Sapkota, Yadav
A1 Chemaitilly, Wassim
A1 Ness, Kirsten K.
A1 Hudson, Melissa M.
A1 Robison, Leslie L.
A1 Bhatia, Smita
A1 Armstrong, Gregory T.
A1 Yasui, Yutaka
YR 2020
UL http://medrxiv.org/content/early/2020/09/23/2020.09.21.20196121.abstract
AB Survivors of childhood cancer treated with radiation therapy (RT) and osteotoxic chemotherapies are at increased risk for fractures. However, research focusing on how genetic and clinical susceptibility factors jointly contribute to fracture risk among long-term (≥5 years) survivors of childhood cancer has been limited. To address this gap, we conducted genome-wide association studies of fracture risk in 2,453 participants from the Childhood Cancer Survivor Study (CCSS) using Cox regression models and prioritized sex- and treatment-stratified genetic associations. Replication analyses were conducted in an independent survivor sample from the St. Jude Lifetime Cohort Study (SJLIFE). We identified a genome-wide significant (P<5⨯10−8) fracture risk locus, 16p13.3 (HAGHL), among female CCSS survivors (N=1,289) with strong evidence of sex-specific effects (Psex-heterogeneity<7⨯10−6). We found rs1406815 showed the strongest association with fracture risk after replication (HRmeta-analysis per risk allele=1.43, P=8.2⨯10−9; N=1,935 women). While the association between rs1406815 and fracture risk was weak among female survivors who did not receive radiation therapy (RT) (HRCCSS=1.22, P=0.11), the association strength increased with greater RT doses to the head or neck (HRCCSS=1.88, P=2.4⨯10−10 in those with any head/neck RT; HRCCSS=3.79, P=9.1⨯10−7 in those treated with >36 Gray). In silico bioinformatics analyses suggest these fracture risk alleles regulate HAGHL gene expression and related bone resorption pathways, and are plausibly moderated by head/neck RT. Genetic risk profiles integrating this locus may help identify young female survivors who would benefit from targeted interventions to reduce fracture risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Cancer Institute (U24 CA55727 to G.T.A., principal investigator, U01 CA195547 to M.M.H. and L.L.R., principal investigators, CA21765 to C. Roberts, Principal Investigator and R01 CA216354 to Y.Y. and J. Zhang principal investigators); Childhood Cancer Survivor Study Career Development Award; and American Lebanese Syrian Associated Charities.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All CCSS and SJLIFE study protocols and contact documents were approved by the institutional review boards of participating study institutions. All study participants provided informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe CCSS data used in this study may be accessed from the database of Genotypes and Phenotypes (dbGaP; https://www.ncbi.nlm.nih.gov/gap/) under accession number phs001327.v1.p1. Data from SJLIFE is available from the St. Jude Cloud (https://www.stjude.cloud/) under accession number SJC-DS-1002.